Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Ther Drug Monit. 2011 Oct;33(5):609–618. doi: 10.1097/FTD.0b013e318228ba39

Table 4.

Evaluation of 1, 3 and 10ng/mL nicotine, cotinine, hydroxycotinine (OH-cotinine), and norcotinine liquid chromatography tandem mass spectrometry cutoffson detection rates of oral fluid specimens collected from participants identified as smokers via A) self-report, B) breath carbon monoxide and C) saliva NicAlert a,b.

A) Self-reported smokers (n=89)
Nicotine Cotinine OH-cotinine Norcotinine Nicotine alone Cotinine alone Nicotine & cotinine Cotinine & OH-cotinine Nicotine & cotinine & OH-cotinine
≥1.0ng/mL 86 87 87 57 0 0 0 1 86
Positive, % 97% 98% 98% 64% 0 0 0 1.1% 97%
Range, ng/mL 2.7–1330.0 24.7–985.0 2.4–454.0 1.2–77.6
≥3.0ng/mL 85 87 86 40 0 0 1 2 84
Positive, % 96% 98% 97% 45% 0 0 1.1% 2.2% 94%
≥10ng/mL 78 87 86 13 0 0 1 9 77
Positive, % 88% 98% 97% 15% 0 0 1.1% 10% 86%
B) Smokers identified by breath carbon monoxide >5ppm (n=86)
≥10ng/mL 77 83 82 13 0 0 1 6 76
Positive, % 90% 96% 95% 15% 0 0 1.2% 7.0% 88%
C) Smokers identified by saliva NicAlert >10ng/mL (n=81)
≥10ng/mL 60 68 66 5 0 1 1 7 59
Positive, % 74% 84% 82% 6.2% 0 1.2% 1.2% 8.6% 73%
a

OH-cotinine and norcotinine were never present without co-occurrence of nicotine or cotinine.

b

Nicotine and OH-cotinine were never found as the only analytes in a single specimen.